Proteomics-based early diagnosis determines the presence of disease by identifying proteins that are specifically expressed in diseases and using these as biomarkers to measure the quantitative values of the relevant proteins in blood.

Proteomics analysis has been assessed as highly likely to be used as a universal primary screening method because analysis can be performed even with trace samples, such as a few drops of blood.

High diagnostic accuracy :
Quantitative values of biomarkers are measured and entered in a unique algorithm with applied AI.

Convenience :
No burden of inconvenience caused due to the use of a separate diagnostic device other than blood sampling

Efficiency:
Provides diagnosis opportunities to more people in situations where personnel and devices are limited